Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial
Abstract
These pilot data suggest that L. rhamnosus GG is safe and efficacious in preventing VAP in a select, high-risk ICU population. Clinical trial registered with www.clinicaltrials.gov (NCT00613795).
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
safety
research support
non-u.s. gov't
adult
female
male
N.I.H.
Extramural
aged
middle aged
Prospective Studies
80 and over
Randomized Controlled Trial
Double-Blind Method
Survival Analysis
diarrhea / prevention & control
pneumonia
pilot projects
diarrhea / microbiology
intention to treat analysis
probiotics / therapeutic use*
probiotics / administration & dosage
clostridioides difficile
pmid:20522788
pmc2970846
doi:10.1164/rccm.200912-1853oc
lee e morrow
marin h kollef
thomas b casale
clostridium infections / prevention & control
lactobacillus rhamnosus*
ventilator-associated / prevention & control*
Access
Citation
ID:
272645
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
272645
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet